Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000022 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
13,962
Total Value
$143,751.91
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 2,875 | $12.65 | $36,368.75 | 54,651 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 1,779 | $8.04 | $14,303.16 | 56,430 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Sale | 4,654 | $20.00 | $93,080.00 | 51,776 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 2,875 | $0.00 | $0.00 | 125,750 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 1,779 | $0.00 | $0.00 | 115,092 | Direct | โ | View Details |